Stocks
Gilead Sciences, Inc.GILD
NASDAQHealthcareBiotechnology$144.99-0.15%
A U.S. biopharmaceutical company focused on antiviral therapies and specialty medicines, with leading franchises in HIV treatment and prevention. Its portfolio also includes therapies for hepatitis, oncology, and cell therapy developed through internal research and acquisitions. Investors closely wa...
Market Cap: $180.0B52W Range: $93.37 – $157.29
Congressional Interest in Gilead Sciences, Inc. (GILD)
17 members of Congress have disclosed 50 trades in Gilead Sciences, Inc. (GILD), a Healthcare company. The buy/sell breakdown shows 36 purchases versus 14 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
17
Buys
36
Sells
14
Who in Congress Is Trading GILD?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-08-26 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2015-08-25 | KENNY MARCHANT | buy | $1K – $15K |